Dysregulation of laminins in intestinal inflammation.

Laminins are structural components of basement membranes that regulate and control many cellular functions. Changes in basement membrane composition play significant roles in etiology of diseases. Inflammatory bowel diseases are conditions that lead to defects in the mucosal barrier which includes the basement membrane underlying the epithelium. This review will summarize the main findings related to the involvement of laminins and of the laminin-binding receptors in inflammatory conditions such as Crohn's disease and ulcerative colitis. We will review the current literature devoted to studies in humans (immunolocalisation, genetic factors, microarray data), as well as experimental cell models that show that laminins contribute to the inflammation process probably linked to the deregulation of proinflammatory cytokines.

[1]  Kathryn Roeder,et al.  Ulcerative colitis loci on chromosomes 1 p 36 and 12 q 15 identified by genome-wide association study , 2009 .

[2]  F. Lubin,et al.  α3β1 integrin induced suppression of the Caco-2 epithelial cell IL-1 signaling pathway leading to NF-κB activation , 2004 .

[3]  Isabelle Cleynen,et al.  Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment , 2009, PloS one.

[4]  Michael Karin,et al.  Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing , 2005, Science.

[5]  A. Maniatis,et al.  Serum laminin and collagen IV in inflammatory bowel disease , 2003, Journal of clinical pathology.

[6]  Alan Ashworth,et al.  Receptor and secreted targets of Wnt-1/β-catenin signalling in mouse mammary epithelial cells , 2005, BMC Cancer.

[7]  R. Mecham,et al.  A Site on Laminin α5, AQARSAASKVKVSMKF, Induces Inflammatory Cell Production of Matrix Metalloproteinase-9 and Chemotaxis1 , 2003, The Journal of Immunology.

[8]  M. Ishii,et al.  Laminin‐332 and ‐511 in skin , 2008, Experimental dermatology.

[9]  M. Kedinger,et al.  The role of the basement membrane as a modulator of intestinal epithelial-mesenchymal interactions. , 2010, Progress in molecular biology and translational science.

[10]  Hans Clevers,et al.  The intestinal stem cell. , 2008, Genes & development.

[11]  F. Lubin,et al.  Regulation of epithelial cell cytokine responses by the α3β1 integrin , 2003 .

[12]  F. Verdam,et al.  Non-invasive assessment of barrier integrity and function of the human gut. , 2010, World journal of gastrointestinal surgery.

[13]  S. Itzkowitz,et al.  Intestinal inflammation and cancer. , 2011, Gastroenterology.

[14]  B. Engelhardt,et al.  Endothelial Cell Laminin Isoforms, Laminins 8 and 10, Play Decisive Roles in T Cell Recruitment across the Blood–Brain Barrier in Experimental Autoimmune Encephalomyelitis , 2001, The Journal of cell biology.

[15]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[16]  V. Koteliansky,et al.  Collagen-binding integrin α1β1 regulates intestinal inflammation in experimental colitis , 2002 .

[17]  S. Dahan,et al.  MicroRNA-7 Modulates CD98 Expression during Intestinal Epithelial Cell Differentiation* , 2009, The Journal of Biological Chemistry.

[18]  T. Virolle,et al.  Transcriptional regulation of laminin gene expression , 2000, Microscopy research and technique.

[19]  J. Clifford,et al.  Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis. , 2011, Physiological genomics.

[20]  G. Roda,et al.  Intestinal epithelial cells in inflammatory bowel diseases. , 2010, World journal of gastroenterology.

[21]  K. Koretz,et al.  Altered content and distribution of tenascin in colitis, colon adenoma, and colorectal carcinoma. , 1992, Gastroenterology.

[22]  L. Peyrin-Biroulet,et al.  Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases. , 2011, World journal of gastroenterology.

[23]  H. Hauri,et al.  Fetal gut mesenchyme induces differentiation of cultured intestinal endodermal and crypt cells. , 1986, Developmental biology.

[24]  E. Ogier-Denis,et al.  Identification of Restricted Subsets of Mature microRNA Abnormally Expressed in Inactive Colonic Mucosa of Patients with Inflammatory Bowel Disease , 2010, PloS one.

[25]  M. Kashiwagi,et al.  Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease , 2009, Nature Medicine.

[26]  P. Donnelly,et al.  Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region , 2010 .

[27]  S. Sugano,et al.  Large-scale identification and characterization of human genes that activate NF-κB and MAPK signaling pathways , 2003, Oncogene.

[28]  S. Targan,et al.  Future therapeutic approaches for inflammatory bowel diseases. , 2011, Gastroenterology.

[29]  V. Quaranta,et al.  Defining the role of laminin-332 in carcinoma. , 2009, Matrix biology : journal of the International Society for Matrix Biology.

[30]  J. Beaulieu,et al.  Proinflammatory cytokines TNF-α and IFN-γ alter laminin expression under an apoptosis-independent mechanism in human intestinal epithelial cells , 2004 .

[31]  P. M. O'Connor,et al.  Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease , 2010, Inflammatory bowel diseases.

[32]  Adam Byron,et al.  Integrin ligands at a glance , 2006, Journal of Cell Science.

[33]  M. Deeg,et al.  Peptides derived from the human laminin α4 and α5 chains exhibit antimicrobial activity , 2010, Peptides.

[34]  Richard O. Hynes,et al.  The Extracellular Matrix: Not Just Pretty Fibrils , 2009, Science.

[35]  H. Clevers,et al.  Tissue-resident adult stem cell populations of rapidly self-renewing organs. , 2010, Cell Stem Cell.

[36]  J. Uitto,et al.  Extracellular matrix protein 1 inhibits the activity of matrix metalloproteinase 9 through high‐affinity protein/protein interactions , 2006, Experimental dermatology.

[37]  D. Schuppan,et al.  MMPs in the gut: inflammation hits the matrix , 2000, Gut.

[38]  J. Stutzmann,et al.  Adhesion complexes implicated in intestinal epithelial cell‐matrix interactions , 2000, Microscopy research and technique.

[39]  M. Shimaoka,et al.  Aberrant activation of integrin α4β7 suppresses lymphocyte migration to the gut , 2007 .

[40]  M. Kedinger,et al.  Heterotypic cellular cooperation in gut morphogenesis and differentiation. , 1993, Seminars in cell biology.

[41]  C. Stipp.  Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets , 2010, Expert Reviews in Molecular Medicine.

[42]  S. Hopkinson,et al.  Laminin deposition in the extracellular matrix: a complex picture emerges , 2009, Journal of Cell Science.

[43]  P. Yurchenco,et al.  Developmental and pathogenic mechanisms of basement membrane assembly. , 2009, Current pharmaceutical design.

[44]  Michael Karin,et al.  Inflammation and colon cancer. , 2010, Gastroenterology.

[45]  E. Seidman,et al.  Degeneration of the pericryptal myofibroblast sheath by proinflammatory cytokines in inflammatory bowel diseases. , 2009, Gastroenterology.

[46]  J. Söderholm,et al.  Importance of disrupted intestinal barrier in inflammatory bowel diseases , 2011, Inflammatory bowel diseases.

[47]  S. Florian,et al.  Deficiency of epithelial basement membrane laminin in ulcerative colitis affected human colonic mucosa , 2000, International Journal of Colorectal Disease.

[48]  J. Korzenik,et al.  Evolving knowledge and therapy of inflammatory bowel disease , 2006, Nature Reviews Drug Discovery.

[49]  H. Hauri,et al.  The differentiating intestinal epithelial cell: establishment and maintenance of functions through interactions between cellular structures. , 1992, Annual review of cell biology.

[50]  M. Nomizu,et al.  Functional Sites in the Laminin Alpha Chains , 2005, Connective tissue research.

[51]  S. Sercu,et al.  The Extracellular Matrix Protein 1: Its Molecular Interaction and Implication in Tumor Progression , 2008, Cancer investigation.

[52]  C. Lees,et al.  Genetics of ulcerative colitis , 2011, Inflammatory bowel diseases.

[53]  J. Miner.  Laminins and their roles in mammals , 2008, Microscopy research and technique.

[54]  J. Beaulieu,et al.  Laminins in the developing and adult human small intestine: Relation with the functional absorptive unit , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[55]  R. Schiestl,et al.  Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models. , 2010, Mutation research.

[56]  K. Midwood,et al.  J. Cell Commun. Signal. (2009) 3:287–310 DOI 10.1007/s12079-009-0075-1 RESEARCH ARTICLE The role of tenascin-C in tissue injury and tumorigenesis , 2009 .

[57]  P. Adegboyega,et al.  Epithelial cells and their neighbors I. Role of intestinal myofibroblasts in development, repair, and cancer. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[58]  T. Macdonald,et al.  Matrix metalloproteinases and the gut - new roles for old enzymes. , 2004, Current opinion in pharmacology.

[59]  L. Sorokin.  The impact of the extracellular matrix on inflammation , 2010, Nature Reviews Immunology.

[60]  A. Schmidtchen,et al.  Antimicrobial activities of heparin-binding peptides. , 2004, European journal of biochemistry.

[61]  N. Miosge,et al.  Basement membrane components are key players in specialized extracellular matrices , 2010, Cellular and Molecular Life Sciences.

[62]  F. Emmrich,et al.  Interaction of enteropathogenic Yersinia enterocolitica with complex basement membranes and the extracellular matrix proteins collagen type IV, laminin-1 and -2, and nidogen/entactin. , 1994, The Journal of biological chemistry.

[63]  J. Chambaz,et al.  E-cadherin-dependent Transcriptional Control of Apolipoprotein A-IV Gene Expression in Intestinal Epithelial Cells , 2006, Journal of Biological Chemistry.

[64]  Joseph T. Glessner,et al.  Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease , 2008, Nature Genetics.

[65]  B. Yacyshyn.  Adhesion molecule therapeutics in IBD. , 2008, Inflammatory bowel diseases.

[66]  J Michael Mathis,et al.  Role of the endothelium in inflammatory bowel diseases. , 2011, World journal of gastroenterology.

[67]  R. Senior,et al.  Fragments of extracellular matrix as mediators of inflammation. , 2008, The international journal of biochemistry & cell biology.

[68]  J. Beaulieu,et al.  Altered expression of laminins in Crohn's disease small intestinal mucosa. , 2000, The American journal of pathology.

[69]  R. Burgeson,et al.  Comparative Analysis of the Distribution of Laminin Chains in the Basement Membranes in Some Malignant Epithelial Tumors: The α1 Chain of Laminin Shows a Selected Expression Pattern in Human Carcinomas , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[70]  Richard A. Flavell,et al.  Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract , 2005, Science.

[71]  M. Nomizu,et al.  The influence of Tribenoside on expression and deposition of epidermal laminins in HaCaT cells. , 2010, Biological & pharmaceutical bulletin.

[72]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[73]  R. Holcombe,et al.  Wnt Pathway-Related Gene Expression in Inflammatory Bowel Disease , 2008, Digestive Diseases and Sciences.

[74]  I. Virtanen,et al.  Immigration check for neutrophils in RA lining: laminin α5 low expression regions act as exit points , 2010, Scandinavian journal of rheumatology.

[75]  Judy H. Cho,et al.  [Letters to Nature] , 1975, Nature.

[76]  Subrata Ghosh,et al.  Natalizumab for active Crohn's disease. , 2003, The New England journal of medicine.

[77]  T. Brabletz,et al.  β‐Catenin activates a coordinated expression of the proinvasive factors laminin‐5 γ2 chain and MT1‐MMP in colorectal carcinomas , 2004 .